Pre-market hot trades in US stocks: D-Wave Quantum pre-market down 9.26%; Polyrizon pre-market up 8.04%

Pre-market Hot Trades in US Stocks

D-Wave Quantum is down 9.26% in pre-market trading. Based on recent key news:

1. On September 19, D-Wave Quantum announced at the Qubits 2025 conference in Japan that its quantum computing technology saw an 83% increase in bookings in the Asia-Pacific region. This news drove the stock price up, but the market still has doubts about its profitability.

2. On September 20, D-Wave Quantum's stock rose 35% over the past week, mainly benefiting from favorable macroeconomic conditions and the company's positive developments at the Qubits 2025 conference.

3. On September 22, a series of bullish catalysts helped D-Wave Quantum's stock rise over 50% this week. The quantum computing industry has performed strongly recently, but risks remain.

Top Gainers in Pre-market US Stocks

Qualigen Therapeutics is up 317.61% in pre-market trading. Based on recent key news:

1. On September 20, Faraday Future announced a private placement investment in Qualigen Therapeutics, totaling approximately $41 million. This move sparked positive market expectations for Qualigen's future development, significantly boosting the stock price. Source: IT Home.

2. On September 22, Qualigen announced it would change its name to CXC10, fully focusing on cryptocurrency business and Web3 ecosystem development. This strategic transformation is seen as an important milestone for the company's future development, further boosting market confidence. Source: IT Home.

3. On September 22, Qualigen faced delisting pressure, with the CEO and CFO resigning. Despite the uncertainty brought by personnel upheaval, market expectations for the new management may partially offset the negative impact. Source: IT Home. The biopharmaceutical industry has a long R&D cycle and high risks